![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 44, 31203-31208, October 29, 1999
From the The conjoint substitution of three active-site
residues in aspartate aminotransferase (AspAT) of Escherichia
coli (Y225R/R292K/R386A) increases the ratio of
L-aspartate In the engineering of protein catalysts with new functional
properties, the modification of existing enzymes provides an
alternative to the production of catalytic antibodies or, in a more
distant future, the de novo design of enzymes. Enzyme
engineering may be expected to contribute to elucidating both the
structural basis of the functional properties and the course of the
molecular evolution. Several attempts to change the substrate
specificity of an enzyme by substitution of the substrate-binding
residues have succeeded (Refs. 1-9; for a review, see Ref. 6). Among
the pyridoxal 5'-phosphate-dependent enzymes, aspartate
aminotransferase (AspAT)1 has
been converted by multiple active-site mutations into an L-tyrosine aminotransferase (5) and by directed molecular
evolution into an L-branched-chain amino acid
aminotransferase (7, 8). Tyrosine phenol-lyase has been engineered by a
double mutation to act as a dicarboxylic-acid The pyridoxal 5'-phosphate (PLP)-dependent enzymes
(B6 enzymes) catalyze numerous reactions in the metabolism
of amino acids. The B6 enzymes are of multiple evolutionary
origin and constitute a few families of homologous proteins of which
the Aspartate aminotransferase is the most extensively studied
B6 enzyme. The homodimeric enzyme (2 × 400 amino acid
residues) catalyzes the reversible transfer of the amino group of
aspartate or glutamate to the cognate oxo acids. A detailed mechanism
of action has been derived from combined biochemical and
crystallographic data (13). In a previous study, we have generated
L-aspartate Here we searched for a third mutation that, if introduced into AspAT
Y225R/R386A, would decrease further transaminase activity without
affecting Oligonucleotide-directed Mutagenesis and Enzyme
Purification--
Oligonucleotide-directed mutagenesis of the
wild-type aspC gene of E. coli inserted into the
BS M13 vector (16) was performed with the mutagenesis kit from Bio-Rad.
The mutations were confirmed by determination of the nucleotide
sequences. The mutated DNAs were expressed in the AspAT-deficient
E. coli strain TY103 (17) with the expression vector pKDHE19
(18). Wild-type and mutant enzymes were purified with previously
described chromatographic procedures. Fractions containing pure AspAT
were pooled, concentrated, and reconstituted with coenzyme as described
(19).
Determination of Protein Concentration and Aminotransferase
Activity--
The concentration of the purified enzymes in the PLP
form was determined spectrophotometrically at 280 nm using the molar absorption coefficient of the subunit,
For measuring the consumption and production of oxo acids, the enzymes
(0.45 mM, subunit concentration) were incubated with 200 mM L-aspartate and 8 mM oxalacetate
in 250 mM 4-methylmorpholine (pH 7.5) at 25 °C. Samples
(40 µl) were deproteinized at different time intervals with 1 M perchloric acid (final concentration) and neutralized
with potassium hydroxide. Oxalacetate and pyruvate were determined
separately by consumption of NADH in the presence of malate
dehydrogenase and lactate dehydrogenase, respectively. The
Measurement of Rates of
For the determination of the rates of desulfination of
L-cysteine sulfinate, the enzymes (0.45 mM,
subunit concentration) were incubated with 100 mM
L-cysteinesulfinic acid and 50 mM
2-oxoglutarate in 200 mM 4-methylmorpholine (pH 7.5) at
25 °C, and the production of alanine was measured as described
above. To check which pathway of X-ray Crystallographic Structure Determination--
Crystals of
AspAT Y225R/R292K/R386A were grown with the hanging drop technique. A
solution containing 15 mg/ml protein, 2 mM
5'-phosphopyridoxyl L-aspartate (13), and 50 mM
4-methylmorpholine (pH 7.5) was mixed 1:1 with reservoir solution
containing 1.98 M ammonium sulfate, 2% (w/v) polyethylene
glycol (Mr 400), and 200 mM
4-methylmorpholine (pH 7.5). Crystals grew to a maximum size of
0.2 × 0.4 × 1.5 mm in ~4 weeks. Nucleation and crystal growth proved more problematic than in the case of wild-type AspAT, probably indicating a less stable conformation of the protein. As found
before for crystals of wild-type and mutant E. coli AspATs (14, 22), the crystals belong to space group P21 with unit cell dimensions a = 88.03 Å, b = 80.32 Å, c = 87.82 Å, and
Diffraction data were collected to a resolution of 2.16 Å, using a
MARresearch imaging plate mounted on a modified Elliott GX20 rotating
copper anode generator. Raw data were processed with MOSFLM (23).
Images were scaled with SCALA and AGROVATA and reduced to structure
factors with TRUNCATE from the CCP4 Program Suite (24). A total of
170,054 measured reflections were merged together with
Rsym = 0.082 to give rise to the data set of
50,068 independent reflections, which is 87.7% complete to 2.16-Å
resolution. The structure of the 5'-phosphopyridoxyl aspartate complex
of AspAT Y225R/R292K/R386A was solved by molecular replacement with the
program AMORE (24), using the refined structure of the open form of the
wild-type enzyme (22) as search model, and refined with TNT (25) to
r = 0.19. The root mean square deviations of the bond
lengths, bond angles, and planes from the ideal values were 0.011 Å,
1.35°, and 0.01 Å, respectively.
Molecular Dynamics Calculation--
The simulations of the
quinonoid intermediates 3 (see Scheme 1) were performed as
described previously (14). The cell multipole method (26) was used
instead of a cutoff for the nonbonded interactions. The modeled
structure of the triple-mutant enzyme was obtained by the replacement
of Arg292 with a lysine residue in the double-mutant crystal
structure. The systems were relaxed by 4000 steps of energy
minimization. The amino acid residues and water molecules beyond a
distance of 11 Å from the coenzyme-substrate adduct were kept fixed
during the following 100 ps of simulation at 300 K.
L-Aspartate
Replacement of Arg292 in AspAT Y225R/R386A with a glutamate or
valine residue led to 16- and 100-fold decreases in
kcat for Transaminase Activity--
The replacement of Arg292 with
lysine, glutamate, valine, or tyrosine in AspAT Y225R/R386A led to a
further marked decrease in kcat for
transamination (Table I). However, only with the R292K substitution as
the third mutation was
AspAT Y225R/R292E/R386A was also tested for activity toward
L-lysine, L-arginine, and
L-ornithine. A very slow transamination reaction of
L-lysine with an initial rate of 0.001 s Desulfination of L-Cysteine Sulfinate--
Wild-type
AspAT catalyzed the transamination of L-cysteine sulfinate
at a very high rate. As a side reaction, elimination of sulfinate
produced L-alanine (Table II). Both AspAT Y225R/R386A and
AspAT Y225R/R292K/R386A showed a reaction specificity that was inverse
to that of the wild-type enzyme, desulfination of L-cysteine sulfinate being by an order of magnitude faster
than its transamination reaction. The double mutation increased
desulfination activity 3-fold and decreased transaminase activity
toward L-cysteine sulfinate by 4 orders of magnitude. The
introduction of the third mutation (R292K) reduced both
desulfination and the transamination activity of the double-mutant
enzyme by an order of magnitude. Lactate dehydrogenase plus NADH had no
effect on kcat of desulfination by the wild-type
and mutant AspATs, indicating that L-alanine is produced by
direct desulfination of L-cysteine sulfinate rather than
through formation of pyruvate followed by transamination.
Crystal Structure--
The 5'-phosphopyridoxyl aspartate complex
of the triple-mutant enzyme (Y225R/R292K/R386A) was found in the open
conformation (Fig. 1). In the wild-type enzyme, binding of dicarboxylic
substrates or inhibitors induces the closed conformation of the enzyme,
in which water molecules are excluded from the vicinity of the Schiff base (13). The open conformation of the triple-mutant enzyme allows
water molecules to enter the active site in the presence of the
substrate analog. Lys258, which is responsible in the
wild-type enzyme (13) for the deprotonation at C- Molecular Dynamics Simulations--
In the simulation of the
external aldimine intermediate based on the crystal structure of AspAT
Y225R/R292K/R386A (Fig. 1), Lys258 did not displace the
intervening water molecule and approach C- The triple mutation Y225R/R292K/R386A brings about a switch in the
reaction specificity of E. coli AspAT. The conjoint R386A and Y225R substitutions enhance the very low L-aspartate
The decrease in transaminase activity observed in both AspAT
Y225R/R386A and AspAT Y225R/R292K/R386A might be due to the repulsion between Lys258 and Arg225 impairing the
reprotonation of the quinonoid intermediate 3 at C-4'. A
possible explanation for the further decrease brought about by the
third mutation (R292K) is provided by the recent crystallographic
analysis of three reaction intermediates of the wild-type enzyme
7 that has shown a water molecule to be positioned near
C- The importance of the domain movement for the reactivity of the
catalytic water molecule in the hydrolysis of the ketimine intermediate
might also explain the reaction pathway of both The starting point of this work was a study of the molecular evolution
of B6 enzymes (11). Within a given family, in particular in
the large Two features of the procedure used in this study for changing the
reaction specificity might be generally applicable to B6 enzymes and perhaps certain other enzymes as well. 1) The double mutation Y225R/R386A shifts an arginine residue from its wild-type position to another position in its immediate vicinity. Such
charge-shifting double mutations may be expected not to disturb greatly
the topochemistry of the active site, but to alter the electron
repartition at the reaction center. 2) Arginine residues are the
preferred binding groups for anionic substrates in enzymes (15). Their
conservative substitution by lysine, which is slightly shorter and
engages in fewer hydrogen bonds, may be expected to change the mode of binding of the substrate.
*
This work was supported in part by Swiss National Science
Foundation Grants 31-45940.95 (to P. C.) and 31-36432.92 (to
J. N. J.) and by a grant from the Cost Action D7 Program of the
European Cooperation in the Field of Scientific and Technical Research (to P. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.:
41-1-6355511; Fax: 41-1-6356805; E-mail:
christen@biocfebs.unizh.ch.
2
V. N. Malashkevich and J. N. Jansonius, unpublished data.
3
Mehta, P. K., and Christen, P. (2000) Adv.
Enzymol. Relat. Areas Mol. Biol., in press.
The abbreviations used are:
AspAT, aspartate
aminotransferase;
PLP, pyridoxal 5'-phosphate;
B6 enzyme, PLP (vitamin B6)-dependent enzyme;
PMP, pyridoxamine 5'-phosphate.
Conversion of Aspartate Aminotransferase into an
L-Aspartate
-Decarboxylase by a Triple Active-site
Mutation*
,
,
,
¶
Biochemisches Institut, Universität
Zürich, Winterthurerstrasse 190, CH-8057 Zürich,
Switzerland and the § Abteilung Strukturbiologie,
Biozentrum, Universität Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-decarboxylase activity to transaminase
activity >25 million-fold. This result was achieved by combining an
arginine shift mutation (Y225R/R386A) with a conservative substitution
of a substrate-binding residue (R292K). In the wild-type enzyme,
Arg386 interacts with the
-carboxylate group of the
substrate and is one of the four residues that are invariant in all
aminotransferases; Tyr225 is in its vicinity, forming a
hydrogen bond with O-3' of the cofactor; and Arg292
interacts with the distal carboxylate group of the substrate. In the
triple-mutant enzyme, kcat' for
-decarboxylation of L-aspartate was 0.08 s
1, whereas kcat' for
transamination was decreased to 0.01 s
1. AspAT was thus
converted into an L-aspartate
-decarboxylase that
catalyzes transamination as a side reaction. The major pathway of
-decarboxylation directly produces L-alanine without
intermediary formation of pyruvate. The various single- or
double-mutant AspATs corresponding to the triple-mutant enzyme showed,
with the exception of AspAT Y225R/R386A, no measurable or only very low
-decarboxylase activity. The arginine shift mutation Y225R/R386A
elicits
-decarboxylase activity, whereas the R292K substitution
suppresses transaminase activity. The reaction specificity of the
triple-mutant enzyme is thus achieved in the same way as that of
wild-type pyridoxal 5'-phosphate-dependent enzymes in
general and possibly of many other enzymes, i.e. by
accelerating the specific reaction and suppressing potential side reactions.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-lyase (an enzyme not
found in nature) that degrades aspartate to pyruvate, ammonia, and
formate (9). However, as yet, no change in the reaction specificity of
an enzyme has been reported, with the exception of the conversion of
papain into a peptide-nitrile hydratase (10). A change in the reaction
specificity may be claimed if a new catalytic activity not inherent in
the wild-type enzyme is generated and the original activity of the
wild-type enzyme is suppressed to a level significantly below that of
the new activity.
-family is by far the largest (11). The enzyme members of the
-family, which includes AspAT, not only possess similar protein
scaffolds, but most of them also share the first two steps of the
reaction pathway (for a succinct introduction into
PLP-dependent reaction pathways, see Ref. 12). The amino
group of the incoming substrate replaces the
-amino group of the
active-site lysine residue, the internal aldimine 1 (see
Scheme 1), thus being followed by the external aldimine intermediate
2, which is then deprotonated at C-
to give the quinonoid
intermediate 3. Only in the subsequent step do the reaction
pathways of the different B6 enzymes diverge, leading to
racemization, transamination,
- and
-elimination and replacement.
It seems therefore feasible to make the quinonoid intermediate
3 in a given enzyme adopt an alternative reaction course by
substituting few critical active-site residues.
-decarboxylase activity in AspAT of
Escherichia coli by introducing a double active-site
mutation (14). AspAT Y225R/R386A
-decarboxylated L-aspartate to L-alanine with
kcat' = 0.08 s
1, i.e.
1330-fold faster than the wild-type enzyme. However, transaminase activity, despite a decrease by 3 orders of magnitude, still exceeded
-decarboxylase activity by a factor of 2.5.
-decarboxylase activity. The only mutation among many
tested that brought about this effect was the replacement of the second
active-site arginine residue, i.e. Arg292 (a residue
of the adjacent subunit of the AspAT homodimer) with lysine. In the
wild-type enzyme, Arg292 binds the distal carboxylate group of
the substrate (Fig. 1). The single R292K
mutation had been previously found to decrease transaminase activity to
0.2% of that of the wild-type enzyme (15). In the triple-mutant
enzyme,
-decarboxylase activity indeed exceeded transaminase
activity by a factor of 8.

View larger version (19K):
[in a new window]
Fig. 1.
Stereo view of the active site of the
5'-phosphopyridoxyl L-aspartate complexes of
AspAT Y225R/R292K/R386A (thick lines) and wild-type AspAT
(thin lines). The asterisks denote residues
from the adjacent subunit. Gly38 and Ile37 were
omitted for clarity. The orientation of the small domain significantly
differed in the two structures (residues 17, 18, 360, 382, and 386;
lower right): 5'-phosphopyridoxyl L-aspartate
(PPL-Asp) locks wild-type AspAT in the closed conformation,
whereas the triple-mutant stays in the open conformation. A water
molecule (Wat) is found in the triple-mutant structure close
to the position of a water molecule that, in mitochondrial AspAT, is
assumed to carry out hydrolysis of the ketimine intermediate (V. N. Malashkevich and J. N. Jansonius, unpublished data).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
= 4.7 × 104 M
1 cm
1 (20).
Kinetic parameters for aminotransferase activities of AspAT mutants and
the wild-type enzyme were measured in a coupled assay with malate
dehydrogenase containing 40 mM L-aspartate plus 20 mM 2-oxoglutarate as substrates for the wild-type enzyme
and 100 mM L-aspartate plus 50 mM
2-oxoglutarate for the mutant enzymes. The values of
kcat refer to subunit concentrations. The
Km' values for L-aspartate and
2-oxoglutarate were measured at fixed concentrations of 2-oxoglutarate
(50 mM) and L-aspartate (200 mM), respectively.
-decarboxylation of oxalacetate in the absence of enzyme (t1/2 = 60 min under the conditions detailed in the
legend of Fig. 2 with 0.45 mM PLP added) was neglected in
the calculations of kcat for the different
enzyme variants.
-Decarboxylation and Other Side
Reactions--
AspATs were incubated with amino acid and their cognate
oxo acid in 250 mM 4-methylmorpholine (pH 7.5). High buffer
concentrations are needed in the assays because CO2 is
released in the
-decarboxylation reaction. The
-decarboxylase
activity of the two mutant enzymes is sensitive to pH; a deviation by
0.5 from the optimum at pH 7.5 decreases the activity by 50% (data not
shown). After addition of 0.5 µmol of L-valine as
internal standard, 20-µl deproteinized samples of the reaction
mixture were derivatized with
2-fluoro-2,4-dinitrophenyl-5-L-alanine amide
(Marfey's reagent) and analyzed as described previously (15,
21).
-elimination the enzymes were
following (see Scheme 1), the same experiments were performed in the
presence of 45 units/ml lactate dehydrogenase and 50 mM
NADH to trap any pyruvate produced by hydrolysis of the ketimine
intermediate 9 (see Scheme 1). Transamination of
L-cysteine sulfinate was quantified by the increase in the
concentration of L-glutamate produced by the reaction of
the PMP form of the enzyme with oxoglutarate.
= 119.85 °.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Decarboxylase Activity--
The
introduction of the additional mutation R292K into AspAT Y225R/R386A
did not affect its L-aspartate
-decarboxylase activity (Fig. 2); the kcat
and Km' values of the triple- and double-mutant
enzymes are the same (Table I). Two
different pathways to produce L-alanine from
L-aspartate are possible, i.e. direct
-decarboxylation of L-aspartate (7
8
1 in Scheme
1) or
-decarboxylation coupled with
transamination (7
9
5),
producing pyruvate, which, by transamination, may be converted to
L-alanine. To determine the partition ratio of the two
pathways, the consumption of oxalacetate (consumed in the reaction with
the PMP form of the enzyme 5 to produce the PLP form
1 and L-aspartate) and the production of
pyruvate in the presence of L-aspartate and oxalacetate
(conditions as described in the legend to Fig. 2) were followed in
parallel with the
-decarboxylation of L-aspartate (Table
II). Both AspAT Y225R/R386A and AspAT
Y225R/R292K/R386A produced pyruvate with a kcat
of only 0.01 s
1, corresponding to a partition ratio
(7
8 versus 7
9) of 8. In the wild-type enzyme, production of pyruvate by
far exceeded that of L-alanine. Probably, most of the
L-alanine produced by the wild-type enzyme was formed by transamination of pyruvate.

View larger version (14K):
[in a new window]
Fig. 2.
-Decarboxylation of
L-aspartate catalyzed by AspAT Y225R/R292K/R386A (
),
AspAT Y225R/R386A (
), and wild-type AspAT (
). Enzymes (0.45 mM, subunit concentration) were incubated with 200 mM L-aspartate and 8 mM oxalacetate
in 250 mM 4-methylmorpholine (pH 7.5) at 25 °C. For
details of the detection of L-alanine, see "Experimental
Procedures."
Kinetic parameters for
-decarboxylase and transaminase activities of
wild-type and mutant AspATs
-decarboxylase assay was carried out in 200 mM
L-aspartate plus 8 mM oxalacetate in 250 mM 4-methylmorpholine (pH 7.5). Transaminasc activity was
measured in the presence of 20 mM L-aspartate
plus 20 mM 2-oxoglutarate in 50 mM
4-methylmorpholine (pH 7.5) for the wild-type enzyme and 100 mM L-aspartate plus 50 mM
2-oxoglutarate in 100 mM 4-methylmorpholine (pH 7.5) for
the mutant enzymes. Because the transaminase activity of AspAT
Y225R/R292E/R386A was too low to be analyzed with a coupled assay, the
transformation of the PLP form of the enzyme into the PMP form upon
addition of 100 mM L-aspartate was followed
spectrophotometrically instead. The disappearance of the PLP form and
the appearance of the PMP form of the enzyme were recorded at 360 and
330 nm, respectively. All reactions were run at 25 °C. One
double-mutant enzyme, AspAT Y225R/R292K, was not expressible in
E. coli TY103. In the cell crude extract, no soluble enzyme
could be detected on SDS-polyacrylamide gel after silver staining.

View larger version (19K):
[in a new window]
Scheme 1.
Reaction pathways of enzymic
transamination and
-replacement.
Comparison of kcat values for
-decarboxylation and
transamination with those of
-desulfination
-decarboxylation, respectively
(Table I). Arg292 was substituted with glutamate to introduce a
negative charge that might destabilize the
-carboxylate group (29,
30) and thus enhance
-decarboxylation. If the ratio of
-decarboxylase to transaminase activity is considered rather than
the absolute kcat value, AspAT Y225R/R292E/R386A
is indeed a more specific L-aspartate
-decarboxylase
than its counterpart with the R292K substitution, its
-decarboxylase
activity being 100 times higher than its transaminase activity (Table
I). Replacement of Arg292 with tyrosine eliminated the positive
charge, whereas the phenolic hydroxy group could still form a hydrogen
bond with the
-carboxylate group of the substrate and thus maintain
the binding function. However, AspAT Y225R/R292Y/R386A proved to have
very low affinity for the substrates and no measurable
-decarboxylase activity.
-decarboxylase activity maintained. The
Km values for dicarboxylic substrates of the
single-, double-, and triple-mutant enzymes are invariably higher than
those of the wild-type enzyme, with the exception of the single Y225R
mutation, which has been reported to decrease the Km
values for C4 and C5 dicarboxylic substrates
(14, 27, 31, 32). In AspAT Y225R/R292K/R386A in particular, the Km values for L-aspartate and
2-oxoglutarate are, as in the Y225R/R386A double-mutant enzyme, seven
and four times higher, respectively, than in the wild-type enzyme.
1
could be detected. Such an effect of a negative charge at position 292 has been reported previously (33-35). Under the same conditions, no
reaction of L-lysine with the wild-type enzyme was
observed. None of the mutant enzymes showed any measurable reaction
other than transamination toward D/L-glutamate,
D-aspartate, L-tyrosine, or
L-serine and their cognate oxo acids.
and reprotonation
at C-4' of the coenzyme (Scheme 1), has moved away from its position
near these atoms, where a water molecule is now found. The amino group
of Lys258 is within hydrogen-bonding distance to
Arg225. Lys292 does not interact with the
distal carboxylate group of the aspartate moiety; it forms a hydrogen
bond with Ser296 instead, whereas a water molecule occupies
its original position. The electron density of the aspartate moiety is
highly disordered due to the lack of Arg292 and
Arg386, which are key residues for substrate binding in the
wild-type enzyme. Nevertheless, the coenzyme-substrate adduct maintains a conformation that allows elimination of the proton at C-
, the C-
-H bond together with the imine nitrogen staying in a plane orthogonal to the plane defined by the coenzyme ring (13, 36).
. This situation most
probably is due to a crystal artifact as it would correspond to a
catalytically inactive enzyme. The dynamics calculations for the
quinonoid intermediate of the triple-mutant enzyme were therefore based
on the crystal structure of AspAT Y225R/R386A (14), in which
Arg292 had been replaced with a lysine residue. In this case,
Lys258 stayed close enough to C-
and C-4' for acting as
the acid-base group in the tautomerization from aldimine 2 to ketimine 4. In the molecular dynamics simulation of the
quinonoid intermediate of AspAT Y225R/R292K/R386A, as in those of AspAT Y225R/R386A, a hydrogen bond between Arg225 and the imine
nitrogen atom is formed (Fig. 3). During
the simulation, this hydrogen bond exists only 5% of the time in AspAT
Y225R, whereas it is present 35% of the time in the double- and
triple-mutant enzymes. In all AspATs containing the Y225R mutation, the
proximity of the positively charged guanidinium group repulses the
protonated Lys258. Its longer distance from C-4' of the
coenzyme hinders reprotonation of that atom and might underlie the
decrease in transaminase activity. In the simulated structures of the
quinonoid intermediate of the wild-type enzyme, Lys258
remains positioned above the imine nitrogen at almost equal distance from C-
and C-4'.

View larger version (18K):
[in a new window]
Fig. 3.
Hydrogen bonds in the active sites of the
quinonoid intermediate 3 of wild-type and mutant AspATs during the
molecular dynamics simulation. The substrate is
L-aspartate. The models represent the averaged structures
of the last 10 ps of 100-ps simulations. The numbers
indicate the fraction of time during which the hydrogen bond exists
during the simulation. Numbers >1 are the sums for all possible
hydrogen bonds of the same atom.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-decarboxylase activity of the wild-type enzyme and decrease
transaminase activity. Measurements of the activity of the pertinent
single- and double-mutant enzymes other than Y225R/R386A confirmed that
the increase in
-decarboxylase activity strictly depends on the
combined effects of the R386A and Y225R substitutions (Table I). This
double mutation amounts to a shift of an arginine residue from position
386 to position 225. The third mutation, replacement of Arg292
with lysine, selectively lowers transaminase activity to one-eighth of
-decarboxylase activity. Together, the three mutations increase the
ratio of
-decarboxylase to transaminase activity >25 million-fold. Molecular dynamics simulations of the wild-type and triple-mutant enzymes based on crystal structures suggested, as previously for the
double-mutant enzyme, that Arg225 makes, in addition to the
hydrogen bond with O-3' of the coenzyme, a second hydrogen bond with
the imine nitrogen of the quinonoid intermediate. In the wild-type
enzyme, the imine nitrogen is not engaged in a hydrogen bond, whereas
O-3' forms a hydrogen bond with Tyr225. The single Y225R
mutation is apparently not sufficient to give rise to the formation of
a hydrogen bond from Arg225 to the imine nitrogen atom
(14). The mutation has been found to decrease the
pKa of the internal aldimine from 6.8 in the
wild-type enzyme to 6.2 due to a strong hydrogen bond of Arg225 with O-3' (27), which pulls electrons out of the
-system extending from the pyridine ring of PLP to the aldimine
bond. The imine nitrogen might thus become a too weak nucleophile to
accept a hydrogen bond from Arg225. The replacement of
Arg386 by an alanine residue has been reported previously
to disrupt the hydrogen-bonding network Arg386
Asn194
O-3' (37) and thus to allow the electrons of
O-3' to flow into the
-system. As a consequence, the imine nitrogen
in the double-mutant enzyme might engage in a hydrogen bond with
Arg225. A similar effect of the Y225R/R386A mutations might
be operative in the quinonoid intermediate (14). The
O-3'-Arg225 and imine nitrogen-Arg225
hydrogen bonds may be assumed to reinforce the electron sink capacity
of the
-system of imine and the cofactor pyridine ring to such an
extent that, even after deprotonation at C-
, it remains effective
enough to stabilize carbanion 6 (Scheme 1), produced by
-decarboxylation. Other factors that might favor
-decarboxylation, such as the angle of the C-
-C-
bond
relative to the coenzyme-imine
-system (36) and negative
electrostatic potentials around the
-carboxylate group that might
promote electron delocalization (38), could not be verified; neither
the bond angles nor the electrostatic potentials in AspAT
Y225R/R292K/R386A were significantly different from those in the
wild-type enzyme.
in the ketimine intermediate 4; this water molecule is
supposed to effect the hydrolysis of the
ketimine.2 Its
nucleophilicity might be enhanced by a hydrogen-bonding network comprising Tyr70, Lys258, and
Gly38. The effect of these interactions is maximal if the
active site is in the closed conformation because the rotation of the
small domain brings Gly38 into a position where it can take
part in this network. The wild-type enzyme assumes the closed
conformation on binding a dicarboxylic amino or oxo acid to the two
active-site arginine residues, Arg292 and Arg386.
By interacting with the substrate, the two arginines are pulled toward
each other, inducing the domain movement (13, 22, 39). In AspAT
Y225R/R292K/R386A, the mutation of both arginine residues prevents the
enzyme from adopting a closed conformation (Fig. 1), with the
consequence that the water molecule might not be reactive enough to
attack C-
. In AspAT Y225R/R386A, with only one substrate-binding
arginine missing, the syncatalytic closure of the active-site cleft is
partially retained (14).
-decarboxylation and
-desulfination. The amino acid L-cysteine sulfinate is a dianion like aspartate and is a physiologic substrate for AspAT (40,
41). The reaction specificity of both AspAT Y225R/R386A and AspAT
Y225R/R292K/R386A toward L-cysteine sulfinate is inverse to
that of the wild-type enzyme. The mutant enzymes desulfinate this
substrate faster than they undergo the transamination reaction with it.
Nevertheless, similar to the wild-type enzyme and in analogy to the
-decarboxylation reaction with aspartate, they preferentially
reprotonate carbanion 7 (Scheme 1) at C-
rather than C-4'
and produce L-alanine (7
8
1) rather than pyruvate (7
9
5). Conceivably, upon loss of the negatively charged
-substituent, the active site assumes the open conformation. Thus,
the frequency of ketimine hydrolysis is decreased, and the partition
ratio is shifted in favor of reprotonation at C-
, resulting in the
production of L-alanine.
-family, a clear temporal sequence of different phases in
the functional specialization is evident. The common ancestor enzyme,
apparently an unspecific all-rounder catalyst, first diverged into
reaction-specific protoenzymes, which then diverged further and
acquired substrate specificity. The last phase for most B6
enzymes was the neutral evolution concomitant with
speciation.3 The conjoint
substitution of three active-site residues that converted AspAT into an
L-aspartate
-decarboxylase seems to simulate the
processes that, in the first phase of molecular evolution, might have
led to reaction-specific B6 enzymes by accelerating the
specific reaction and suppressing potential side reactions. To the best
of our knowledge, such a clear change in reaction specificity with a
remarkably high new activity (kcat = 0.08 s
1) has as yet only been reported for papain that was
converted into a peptide-nitrile hydratase by a single amino acid
substitution at the active site (10).
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Wilks, H. M.,
Hart, K. W.,
Freeney, R.,
Dunn, C. R.,
Muirhead, H.,
Chia, W. N.,
Barstow, D. A.,
Atkinson, T.,
Clarke, A. R.,
and Holbrook, J. J.
(1988)
Science
242,
1541-1544 2.
Bradley, M.,
Bücheler, U. S.,
and Walsh, C. T.
(1991)
Biochemistry
30,
6124-6127[CrossRef][Medline]
[Order article via Infotrieve]
3.
Scutton, N. S.,
Berry, A.,
and Perham, R. N.
(1990)
Nature
343,
38-43[CrossRef][Medline]
[Order article via Infotrieve]
4.
Hedstrom, L.,
Szilagyi, L.,
and Rutter, W. J.
(1992)
Science
255,
1249-1253 5.
Onuffer, J. J.,
and Kirsch, J. F.
(1995)
Protein Sci.
4,
1750-1757[Abstract]
6.
Shao, Z.,
and Arnold, F. H.
(1996)
Curr. Opin. Struct. Biol.
6,
513-518[CrossRef][Medline]
[Order article via Infotrieve]
7.
Yano, T.,
Oue, S.,
and Kagamiyama, H.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
5511-5515 8.
Oue, S.,
Okamoto, A.,
Yano, T.,
and Kagamiyama, H.
(1999)
J. Biol. Chem.
274,
2344-2349 9.
Mouratou, B.,
Kasper, P.,
Gehring, H.,
and Christen, P.
(1999)
J. Biol. Chem.
274,
1320-1325 10.
Dufour, E.,
Storer, A. C.,
and Ménard, R.
(1995)
Biochemistry
34,
16382-16388[CrossRef][Medline]
[Order article via Infotrieve]
11.
Alexander, F. W.,
Sandmeier, E.,
Mehta, P. K.,
and Christen, P.
(1994)
Eur. J. Biochem.
219,
953-960[Medline]
[Order article via Infotrieve]
12.
Metzler, D. E.
(1977)
Biochemistry
, pp. 444-461, Academic Press, Orlando, FL
13.
Kirsch, J. F.,
Eichele, G.,
Ford, G. C.,
Vincent, M. G.,
Jansonius, J. N.,
Gehring, H.,
and Christen, P.
(1984)
J. Mol. Biol.
174,
497-525[CrossRef][Medline]
[Order article via Infotrieve]
14.
Graber, R.,
Kasper, P.,
Malashkevich, V. N.,
Sandmeier, E.,
Berger, P.,
Gehring, H.,
Jansonius, J. N.,
and Christen, P.
(1995)
Eur. J. Biochem.
232,
686-690[Medline]
[Order article via Infotrieve]
15.
Vacca, R. A.,
Giannattasio, S.,
Graber, R.,
Sandmeier, E.,
Marra, E.,
and Christen, P.
(1997)
J. Biol. Chem.
272,
21932-21937 16.
Malcolm, B. A.,
and Kirsch, J. F.
(1985)
Biochem. Biophys. Res. Commun.
132,
915-921[CrossRef][Medline]
[Order article via Infotrieve]
17.
Yano, T.,
Kuramitsu, S.,
Tanase, S.,
Morino, Y.,
Hiromi, K.,
and Kagamiyama, H.
(1991)
J. Biol. Chem.
266,
6079-6085 18.
Kamitori, S.,
Hirotsu, K.,
Higuchi, T.,
Kondo, K.,
Inoue, K.,
Kuramitsu, S.,
Kagamiyama, H.,
Higuchi, Y.,
Yasuoka, N.,
Kusunoki, M.,
and Matsuura, Y.
(1987)
J. Biochem. (Tokyo)
101,
813-816 19.
Vacca, R. A.,
Christen, P.,
Malashkevich, V. N.,
Jansonius, J. N.,
and Sandmeier, E.
(1995)
Eur. J. Biochem.
227,
481-487[Medline]
[Order article via Infotrieve]
20.
Kuramitsu, S.,
Hiromi, K.,
Hayashi, H.,
Morino, Y.,
and Kagamiyama, H.
(1990)
Biochemistry
29,
5469-5476[CrossRef][Medline]
[Order article via Infotrieve]
21.
Kochhar, S.,
and Christen, P.
(1988)
Eur. J. Biochem.
175,
433-438[Medline]
[Order article via Infotrieve]
22.
Jäger, J.,
Moser, M.,
Sauder, U.,
and Jansonius, J. N.
(1994)
J. Mol. Biol.
239,
285-305[CrossRef][Medline]
[Order article via Infotrieve]
23.
Leslie, A. G. V.
(1994)
MOSFLM Users Guide
, Medical Research Council-Laboratory of Molecular Biology, Cambridge
24.
CCP4 Program Suite: Collaborative Computing Project No. 4.
(1994)
Acta Crystallogr. Sect. D
50,
760-763[CrossRef][Medline]
[Order article via Infotrieve]
25.
Tronrud, D. E.,
Ten Eyck, L. F.,
and Matthews, B. W.
(1987)
Acta Crystallogr. Sect. A
43,
489-501[CrossRef]
26.
Greengard, L.,
and Rokhlin, V. I.
(1987)
J. Comp. Physiol.
73,
325-330
27.
Inoue, K.,
Kuramitsu, S.,
Okamoto, A.,
Hirotsu, K.,
Higuchi, T.,
Morino, Y.,
and Kagamiyama, H.
(1991)
J. Biochem. (Tokyo)
109,
570-576 28.
Furumo, N. C.,
and Kirsch, J. F.
(1995)
Arch. Biochem. Biophys.
319,
49-54[CrossRef][Medline]
[Order article via Infotrieve]
29.
Leussing, D. L.,
and Raghavan, N. V.
(1980)
J. Am. Chem. Soc.
102,
5635-5643[CrossRef]
30.
Hurley, J. H.,
and Remington, S. J.
(1992)
J. Am. Chem. Soc.
114,
4769-4773[CrossRef]
31.
Goldberg, J. M.,
Swanson, R. V.,
Goodman, H. S.,
and Kirsch, J. F.
(1991)
Biochemistry
30,
305-312[CrossRef][Medline]
[Order article via Infotrieve]
32.
Goldberg, J. M.,
and Kirsch, J. F.
(1996)
Biochemistry
35,
5280-5291[CrossRef][Medline]
[Order article via Infotrieve]
33.
Cronin, C. N.,
and Kirsch, J. F.
(1988)
Biochemistry
27,
4572-4579[CrossRef][Medline]
[Order article via Infotrieve]
34.
Hwang, J. K.,
and Warshel, A.
(1988)
Nature
334,
270-272[CrossRef][Medline]
[Order article via Infotrieve]
35.
Almo, S. C.,
Smith, D. L.,
Danishefsky, A. T.,
and Ringe, D.
(1994)
Protein Eng.
7,
405-412 36.
Dunathan, H. C.
(1966)
Proc. Natl. Acad. Sci. U. S. A.
55,
712-716 37.
Yano, T.,
Mizuni, T.,
and Kagamiyama, H.
(1993)
Biochemistry
32,
1810-1815[CrossRef][Medline]
[Order article via Infotrieve]
38.
Gallagher, T.,
Snell, E. E.,
and Hackert, M. L.
(1989)
J. Biol. Chem.
264,
12737-12743 39.
Picot, D.,
Sandmeier, E.,
Thaller, C.,
Vincent, M. G.,
Christen, P.,
and Jansonius, J. N.
(1991)
Eur. J. Biochem.
196,
329-341[Medline]
[Order article via Infotrieve]
40.
Parsons, B.,
and Rainbow, T. C.
(1984)
Brain Res.
294,
193-197[CrossRef][Medline]
[Order article via Infotrieve]
41.
Weinstein, C. L.,
Haschemeyer, R. H.,
and Griffith, O. W.
(1988)
J. Biol. Chem.
263,
16568-16579
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W. C. Lee, T. Ohshiro, T. Matsubara, Y. Izumi, and M. Tanokura Crystal Structure and Desulfurization Mechanism of 2'-Hydroxybiphenyl-2-sulfinic Acid Desulfinase J. Biol. Chem., October 27, 2006; 281(43): 32534 - 32539. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Liepman and L. J. Olsen Alanine Aminotransferase Homologs Catalyze the Glutamate:Glyoxylate Aminotransferase Reaction in Peroxisomes of Arabidopsis Plant Physiology, January 1, 2003; 131(1): 215 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bertoldi, M. Gonsalvi, R. Contestabile, and C. B. Voltattorni Mutation of Tyrosine 332 to Phenylalanine Converts Dopa Decarboxylase into a Decarboxylation-dependent Oxidative Deaminase J. Biol. Chem., September 20, 2002; 277(39): 36357 - 36362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roth and A. Jeltsch Changing the target base specificity of the EcoRV DNA methyltransferase by rational de novo protein-design Nucleic Acids Res., August 1, 2001; 29(15): 3137 - 3144. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||